Kepivance Market Report 2026

Kepivance Market Overview

• The Kepivance market growth in the historic period has been driven by high incidence of oral mucositis in chemotherapy, limited effective preventive options • Market expansion is supported by rising cancer treatment volumes, growth in hematopoietic stem cell transplants • Growth Driver: Impact Of Rising Cancer Prevalence On The Growth Of The Kepivance Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Kepivance Market?

Kepivance (palifermin) is a recombinant human keratinocyte growth factor (KGF) designed to stimulate the growth of epithelial cells. It is primarily used to reduce the incidence and severity of oral mucositis in patients undergoing myelotoxic cancer therapy, such as hematopoietic stem cell transplantation. Kepivance helps alleviate pain and improve the quality of life during treatment by promoting the repair and regeneration of the oral mucosa. The main indication types of kepivance are prevention of oral mucositis and treatment of oral mucositis. Oral mucositis is a painful condition that often occurs as a side effect of chemotherapy or radiation therapy. The formulations are injectable formulations and lyophilized powders for reconstitution, and the routes of administration include intramuscular injection and subcutaneous injection. The distribution channels are direct sales, wholesalers and distributors, retail pharmacies, and online pharmacies, and it is used by various end users such as hospitals, oncology clinics, hematology treatment centers, and home healthcare providers.

What Is The Kepivance Market Growth Forecast?

The growth in the forecast period can be attributed to rising cancer treatment volumes, growth in hematopoietic stem cell transplants, focus on patient quality of life, increasing supportive oncology budgets, advancements in epithelial regeneration therapies. Major trends in the forecast period include rising focus on supportive oncology care, growth in stem cell transplant procedures, increased management of treatment induced mucositis, preference for preventive mucositis therapies, integration of growth factors in oncology protocols.

Global Kepivance Market Segmentation

1) By Indication: Prevention Of Oral Mucositis, Treatment Of Oral Mucositis 2) By Formulation: Injectable Formulation, Lyophilized Powder For Reconstitution 3) By Route Of Administration: Intramuscular Injection, Subcutaneous Injection 4) By Distribution Channel: Direct Sales, Wholesalers And Distributor, Retail Pharmacies, Online Pharmacies 5) By End-User: Hospitals, Oncology Clinics, Hematology Treatment Centers, Home Healthcare Providers

What Are The Drivers Of The Kepivance Market?

The increasing prevalence of cancer is expected to propel the growth of the kepivance market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. The increasing prevalence of cancer can be attributed to several factors, including an aging population, lifestyle factors such as poor diet and smoking, better diagnosis and screening techniques, and improved survival rates due to advancements in cancer treatments. Kepivance, a medication used to treat mucositis caused by chemotherapy or radiation in cancer patients, helps alleviate the painful symptoms of oral mucositis, improving the quality of life and enabling patients to continue with their cancer treatment regimen. For instance, in January 2024, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of cancer cases increased to 2,001,140 compared to 1,958,310 in 2023, reflecting a growth of 2.19%. Therefore, the increasing prevalence of cancer is driving the kepivance industry. The expansion of healthcare infrastructure is expected to accelerate the growth of kepivance market going forward. Healthcare infrastructure refers to the physical and organizational structures, facilities, and resources necessary to deliver healthcare services effectively to a population. The expansion of healthcare infrastructure is due to factors such as population growth, aging populations, the rise of chronic diseases, and the need for more accessible care. Healthcare infrastructure supports the administration of Kepivance by providing specialized facilities and trained professionals for its intravenous delivery and monitoring during cancer therapy. For instance, in January 2025, according to Sports Medical, a UK-based healthcare industry publication, hospitals remained the dominant segment in UK healthcare construction accounting for 41% of health project starts in 2024 at $2.61 billion (£2bn) representing a 9% year on year increase, while nursing homes accounted for 17% of project starts at $1.07 billion (£822m) showing a 25% increase. Therefore, the expansion of healthcare infrastructure is driving the growth of the kepivance industry. Growing focus on personalized medicine is expected to enhance the kepivance market going forward. Personalized medicine is a medical approach that tailors treatment and healthcare decisions to the individual characteristics, needs, and genetic profile of each patient. The growing demand for personalized medicine is driven by advancements in genomics, targeted therapies, and the increasing prevalence of chronic diseases that require more precise treatment approaches. Personalized medicine enhances the use of kepivance (palifermin) by tailoring its administration to patients undergoing high-dose chemotherapy and stem cell transplants, optimizing protection against oral mucositis based on individual risk factors. For instance, in February 2024, according to Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, a growing focus on personalized medicine drives the kepivance industry.

Key Players In The Global Kepivance Market

Major companies operating in the kepivance market are Biovitrum AB

Regional Insights

North America was the largest region in the kepivance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Kepivance Market?

The kepivance market consists of sales of palifermin-based therapies. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Kepivance Market Report 2026?

The kepivance market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the kepivance industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.